ChemGenex uses genomics approach to develop new anticancer drug and predict possible side effects
Understanding how genes respond to chemicals in diseased and normal tissues, in both cell cultures and living systems, can help researchers develop new drugs more efficiently. Such knowledge can spotlight drug toxicities, help select dosing regimens for clinical trials, and identify which patients may best benefit from treatment. Researchers from ChemGenex present data showing the use of chemical genomics and informatics in the development of a new cancer therapeutic, now in Phase I/II human testing.
J. Kureczka Associates
Message posted by: Wouter Kalle